190 related articles for article (PubMed ID: 10411895)
1. Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes.
Thomas JT; Hubert WG; Ruesch MN; Laimins LA
Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8449-54. PubMed ID: 10411895
[TBL] [Abstract][Full Text] [Related]
2. The chromatin structure of the long control region of human papillomavirus type 16 represses viral oncoprotein expression.
Stünkel W; Bernard HU
J Virol; 1999 Mar; 73(3):1918-30. PubMed ID: 9971771
[TBL] [Abstract][Full Text] [Related]
3. P53 represses human papillomavirus type 16 DNA replication via the viral E2 protein.
Brown C; Kowalczyk AM; Taylor ER; Morgan IM; Gaston K
Virol J; 2008 Jan; 5():5. PubMed ID: 18190682
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of human papillomaviruses in differentiating epithelia.
Longworth MS; Laimins LA
Microbiol Mol Biol Rev; 2004 Jun; 68(2):362-72. PubMed ID: 15187189
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous human papillomavirus type 38 E7 regulates actin cytoskeleton structure for increasing cell proliferation through CK2 and the eukaryotic elongation factor 1A.
Yue J; Shukla R; Accardi R; Zanella-Cleon I; Siouda M; Cros MP; Krutovskikh V; Hussain I; Niu Y; Hu S; Becchi M; Jurdic P; Tommasino M; Sylla BS
J Virol; 2011 Sep; 85(17):8477-94. PubMed ID: 21697493
[TBL] [Abstract][Full Text] [Related]
6. Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31.
Lee C; Laimins LA
J Virol; 2004 Nov; 78(22):12366-77. PubMed ID: 15507623
[TBL] [Abstract][Full Text] [Related]
7. Human papillomaviruses and the interferon response.
Beglin M; Melar-New M; Laimins L
J Interferon Cytokine Res; 2009 Sep; 29(9):629-35. PubMed ID: 19715460
[TBL] [Abstract][Full Text] [Related]
8. Transforming properties of ovine papillomaviruses E6 and E7 oncogenes.
Tore G; Dore GM; Cacciotto C; Accardi R; Anfossi AG; Bogliolo L; Pittau M; Pirino S; Cubeddu T; Tommasino M; Alberti A
Vet Microbiol; 2019 Mar; 230():14-22. PubMed ID: 30827380
[TBL] [Abstract][Full Text] [Related]
9. Amplification of the chromosome 20q region is associated with expression of HPV-16 E7 in human airway and anogenital epithelial cells.
Klingelhutz AJ; Qian Q; Phillips SL; Gourronc FA; Darbro BW; Patil SR
Virology; 2005 Sep; 340(2):237-44. PubMed ID: 16051300
[TBL] [Abstract][Full Text] [Related]
10. Autophagy regulates UBC9 levels during viral-mediated tumorigenesis.
Mattoscio D; Casadio C; Miccolo C; Maffini F; Raimondi A; Tacchetti C; Gheit T; Tagliabue M; Galimberti VE; De Lorenzi F; Pawlita M; Chiesa F; Ansarin M; Tommasino M; Chiocca S
PLoS Pathog; 2017 Mar; 13(3):e1006262. PubMed ID: 28253371
[TBL] [Abstract][Full Text] [Related]
11. Role of the DNA Damage Response in Human Papillomavirus RNA Splicing and Polyadenylation.
Nilsson K; Wu C; Schwartz S
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895741
[TBL] [Abstract][Full Text] [Related]
12. Novel recombinant papillomavirus genomes expressing selectable genes.
Van Doorslaer K; Porter S; McKinney C; Stepp WH; McBride AA
Sci Rep; 2016 Nov; 6():37782. PubMed ID: 27892937
[TBL] [Abstract][Full Text] [Related]
13. Focal Adhesion Kinase Binds to the HPV E2 Protein to Regulate Initial Replication after Infection.
Jose L; Gonzalez J; Kessinger E; Androphy EJ; DeSmet M
Pathogens; 2023 Sep; 12(10):. PubMed ID: 37887719
[TBL] [Abstract][Full Text] [Related]
14. Papillomaviruses and cancer: from basic studies to clinical application.
zur Hausen H
Nat Rev Cancer; 2002 May; 2(5):342-50. PubMed ID: 12044010
[TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine.
Harro CD; Pang YY; Roden RB; Hildesheim A; Wang Z; Reynolds MJ; Mast TC; Robinson R; Murphy BR; Karron RA; Dillner J; Schiller JT; Lowy DR
J Natl Cancer Inst; 2001 Feb; 93(4):284-92. PubMed ID: 11181775
[TBL] [Abstract][Full Text] [Related]
16. The human papillomavirus type 16 E7 oncogene is required for the productive stage of the viral life cycle.
Flores ER; Allen-Hoffmann BL; Lee D; Lambert PF
J Virol; 2000 Jul; 74(14):6622-31. PubMed ID: 10864676
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology, Molecular Pathogenesis, Immuno-Pathogenesis, Immune Escape Mechanisms and Vaccine Evaluation for HPV-Associated Carcinogenesis.
Jain M; Yadav D; Jarouliya U; Chavda V; Yadav AK; Chaurasia B; Song M
Pathogens; 2023 Nov; 12(12):. PubMed ID: 38133265
[TBL] [Abstract][Full Text] [Related]
18. The antiviral effects of a MEK1/2 inhibitor promote tumor regression in a preclinical model of human papillomavirus infection-induced tumorigenesis.
Luna AJ; Young JM; Sterk RT; Bondu V; Schultz FA; Kusewitt DF; Kang H; Ozbun MA
Antiviral Res; 2023 Aug; 216():105667. PubMed ID: 37429527
[TBL] [Abstract][Full Text] [Related]
19. The SETD2 Methyltransferase Supports Productive HPV31 Replication through the LEDGF/CtIP/Rad51 Pathway.
Mac M; DeVico BM; Raspanti SM; Moody CA
J Virol; 2023 May; 97(5):e0020123. PubMed ID: 37154769
[TBL] [Abstract][Full Text] [Related]
20. Like Brothers in Arms: How Hormonal Stimuli and Changes in the Metabolism Signaling Cooperate, Leading HPV Infection to Drive the Onset of Cervical Cancer.
Läsche M; Gallwas J; Gründker C
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
